Virios Therapeutics
Ralph Grosswald has an extensive background in operations and research within the biotech and healthcare industry. With experience at companies like Virios Therapeutics, Celtaxsys Inc, GMP Companies, and National Cardiovascular Network, Ralph has been involved in managing novel drug development, financing, outcomes research, and data analysis. Ralph's educational background includes a Master of Public Health degree from Emory University.
Virios Therapeutics
Virios Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM).